MMSI's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 688.61 -- higher than 94.92% of US-listed equities with positive expected earnings growth.
Price to trailing twelve month operating cash flow for MMSI is currently 25.89, higher than 86.08% of US stocks with positive operating cash flow.
In terms of twelve month growth in earnings before interest and taxes, Merit Medical Systems Inc is reporting a growth rate of -89.88%; that's higher than merely 17.55% of US stocks.
Stocks that are quantitatively similar to MMSI, based on their financial statements, market capitalization, and price volatility, are QBAK, ELAN, TRUP, ENV, and NTCT.
MMSI's SEC filings can be seen here. And to visit Merit Medical Systems Inc's official web site, go to www.merit.com.
Merit Medical Systems is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. The company was founded in 1987 and is based in South Jordan, Utah.
MMSI Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Merit Medical Systems Inc. To summarize, we found that Merit Medical Systems Inc ranked in the 11th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 90%. As for the metrics that stood out in our discounted cash flow analysis of Merit Medical Systems Inc, consider:
Merit Medical Systems Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at 0.48. This coverage rate is greater than that of only 24.7% of stocks we're observing for the purpose of forecasting via discounted cash flows.
As a business, Merit Medical Systems Inc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than just 0% of stocks generating free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Merit Medical Systems Inc? See MYGN, RGEN, EHC, MOH, and CMD.
The WRAPSODY system is a flexible self-expanding endoprosthesis indicated for use in hemodialysis patients for the treatment of stenosis or occlusion within central veins as well as the dialysis outflow circuit of an arteriovenous (AV) fistula or AV graft. Merit has worked for almost eight years to design, develop and establish the appropriate technology and manufacturing capabilities for this product. Merit recently completed enrollment and primary follow-up of its WRAPSODY FIRST study which included 46 patients in Europe.
SAN DIEGO & SOUTH JORDAN, Utah--(BUSINESS WIRE)---- $MMSI #ClassAction--Shareholder rights law firm Robbins LLP announces that it is investigating Merit Medical Systems, Inc. (NASDAQ: MMSI) for alleged violations of the Securities Exchange Act of 1934 and whether the Company's officers and directors breached their fiduciary duties to shareholders. Merit manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutics. If you suffered a loss as a result of Merit's misconduct, click